Ross A M
Cardiovasc Clin. 1989;20(1):209-18.
This decade has witnessed the establishment of thrombolysis, the most widely available therapeutic intervention that specifically treats the direct cause of myocardial infarction and leads to biologically and clinically compelling patient outcome benefits. The next series of investigational tasks will refine issues such as patient and drug selection and optimal postlysis strategies.
这十年见证了溶栓疗法的建立,这是最广泛应用的治疗干预措施,它专门针对心肌梗死的直接病因进行治疗,并在生物学和临床上为患者带来了显著的治疗效果。接下来的一系列研究任务将完善诸如患者和药物选择以及最佳溶栓后策略等问题。